Related Experiment Video

Updated: Aug 9, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment

E Nordborg1, C Nordborg

  • 1Department of Rheumatology, Sahlgrenska University Hospital, SE-413 45, Göteborg, Sweden. nordborg@swipnet.se

Rheumatology (Oxford, England)
|March 11, 2003
PubMed

Insights

Giant cell arteritis (GCA) is a chronic vasculitis primarily affecting older women, targeting large arteries. While not infectious, seasonal variations in incidence suggest environmental triggers, with corticosteroids remaining the primary treatment.

Area of Science:

  • Rheumatology
  • Immunology
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) is a chronic systemic vasculitis.
  • It predominantly affects elderly women and targets large to medium-sized arteries, notably the aorta and its extracranial branches.
  • The age and sex distribution is linked to degenerative arterial changes.

Purpose of the Study:

  • To summarize the key characteristics of Giant Cell Arteritis.
  • To discuss potential triggering factors and epidemiological patterns.
  • To review current treatment strategies.

Main Methods:

  • Review of existing literature and morphological observations.
  • Analysis of epidemiological data regarding incidence and seasonal variations.
  • Discussion of treatment modalities.

Main Results:

  • GCA exhibits a strong female predominance and affects older individuals.
  • The disease primarily involves the aorta and its extracranial branches.
  • Significant seasonal variations in GCA incidence have been observed, suggesting potential environmental triggers, though it is not considered a purely infectious vasculitis.
  • Mortality is not increased in adequately treated patients.

Conclusions:

  • Giant cell arteritis is a complex vasculitis influenced by age, sex, and possibly environmental factors.
  • Corticosteroids remain the mainstay of treatment, despite the exploration of steroid-sparing alternatives.
  • Further research into triggers may elucidate preventative strategies.

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...